Abstract:Abstract Background Allergic diseases typically refer to a heterogeneous group of conditions primarily caused by the activation of mast cells or eosinophils, including atopic dermatitis (AD), allergic rhinitis (AR), and asthma. Asthma, AR, and AD collectively affect approximately one‐fifth of the global population, imposing a significant economic burden on society. Despite the availability of drugs to treat allergic diseases, they have been shown to be insufficient in controlling relapses and halting disease progression. Therefore, new drug targets are needed to prevent the onset of allergic diseases. Method We employed a Mendelian randomization approach to identify potential drug targets for the treatment of allergic diseases. Leveraging 1798 genetic instruments for 1537 plasma proteins from the latest reported Genome‐Wide Association Studies (GWAS), we analyzed the GWAS summary statistics of Ferreira MA et al. (nCase = 180,129, nControl = 180,709) using the Mendelian randomization method. Furthermore, we validated our findings in the GWAS data from the FinnGen and UK Biobank cohorts. Subsequently, we conducted sensitivity tests through reverse causal analysis, Bayesian colocalization analysis, and phenotype scanning. Additionally, we performed protein‐protein interaction analysis to determine the interaction between causal proteins. Finally, based on the potential protein targets, we conducted molecular docking to identify potential drugs for the treatment of allergic diseases. Results At Bonferroni significance ( p < 3.25 × 10 −5 ), the Mendelian randomization analysis revealed 11 significantly associated protein‐allergic disease pairs. Among these, the increased levels of TNFAIP3, ERBB3, TLR1, and IL1RL2 proteins were associated with a reduced risk of allergic diseases, with corresponding odds ratios of 0.82 (0.76–0.88), 0.74 (0.66–0.82), 0.49 (0.45–0.55), and 0.81 (0.75–0.87), respectively. Conversely, increased levels of IL6R, IL1R1, ITPKA, IL1RL1, KYNU, LAYN, and LRP11 proteins were linked to an elevated risk of allergic diseases, with corresponding odds ratios of 1.04 (1.03–1.05), 1.25 (1.18–1.34), 1.48 (1.25–1.75), 1.14 (1.11–1.18), 1.09 (1.05–1.12), 1.96 (1.56–2.47), and 1.05 (1.03–1.07), respectively. Bayesian colocalization analysis suggested that LAYN (coloc.abf‐PPH4 = 0.819) and TNFAIP3 (coloc.abf‐PPH4 = 0.930) share the same variant associated with allergic diseases. Conclusions Our study demonstrates a causal association between the expression levels of TNFAIP3 and LAYN and the risk of allergic diseases, suggesting them as potential drug targets for these conditions, warranting further clinical investigation.

Dominant atopy risk mutations identified by mouse forward genetic analysis

Familial Aggregation Of Skin Sensitization To Aeroallergens In A Rural Area In China

Identification of Candidate Genes in Atopic Dermatitis Based on Bioinformatic Methods

Genetic Variants in Hippo Pathway Genes Are Associated with House Dust Mite‐induced Allergic Rhinitis in a Chinese Population

Association Study on ADAM33 Polymorphisms in Mite-Sensitized Persistent Allergic Rhinitis in a Chinese Population.

Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study

The Effects Of Overexpression Of Histamine Releasing Factor (Hrf) In A Transgenic Mouse Model

Multi-ancestry Genome-Wide Association Study of 21,000 Cases and 95,000 Controls Identifies New Risk Loci for Atopic Dermatitis.

Data from Genome-Wide Association and Fine Mapping of Genetic Loci Predisposing to Colon Carcinogenesis in Mice

A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 mice

The role of PTPN22 in autoimmunity: learning from mice

Eleven loci with new reproducible genetic associations with allergic disease risk.

Coordinated DNA Methylation and Gene Expression Data for Identification of the Critical Genes Associated with Childhood Atopic Asthma

Dynamic responses of human lung innate and adaptive immune cells highlight the roles of genes at asthma risk loci

Asthmatic Airway Neutrophilia after Allergen Challenge is Associated with the Glutathione S-Transferase M1 Genotype

Trans-ethnic analysis in over 780,000 individuals yields new insights into the genetic etiology of allergic diseases

Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease

A Heuristic Approach to Analysis of the Genetic Susceptibility Profile in Patients Affected by Airway Allergies

Targeted resequencing showing novel common and rare genetic variants increases the risk of asthma in the Chinese Han population

Shared Genetic Origin of Asthma, Hay Fever and Eczema Elucidates Allergic Disease Biology.

Pathogenic role of different phenotypes of immune cells in airway allergic diseases: a study based on Mendelian randomization